(E)-2-Phenylpropenyl acetate
Common Name: |
(E)-2-Phenylpropenyl acetate |
IUPAC Name: |
[(E)-2-phenylprop-1-enyl] acetate |
Molecular Formula: |
C12H18N2O |
SMILES: |
CC(=COC(=O)C)C1=CC=CC=C1 |
Inchi: |
1S/C11H12O2/c1-9(8-13-10(2)12)11-6-4-3-5-7-11/h3-8H,1-2H3/b9-8+ |
Inchi Key: |
CLCGEEANBAUENX-CMDGGOBGSA-N |
Cas No: |
37973-51-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
206.28 |
Mass (g/mol) |
176.084 |
Molar Refractivity |
68.83 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
26.71 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
249.00 to 250.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.023 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.611 |
iLOGP |
2.15 |
XLOGP3 |
0.97 |
WLOGP |
0.02 |
MLOGP |
1.13 |
ESOL Log S |
-1.89 |
ESOL Solubility (mg/ml) |
2.63 |
ESOL Solubility (mol/l) |
0.013 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.12 |
Ali Solubility (mg/ml) |
15.7 |
Ali Solubility (mol/l) |
0.08 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.40 |
Silicos-IT Solubility (mg/ml) |
0.82 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-6.87 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.761 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.793 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |